510(k) Report

510(k) · Cleared

Cleared

HYBRID Guidewire

K182337510(k) TraditionalCleared Oct 4, 201837-day reviewClass II21 CFR 870.1330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Balt USA, LLC · MOF Guide, Wire, Catheter, Neurovasculature

Cleared on Oct 4, 2018 as substantially equivalent to K133725 (MicroVention, Inc., 2014) after a 37-day review. Its family tree reaches back 5 generations to 1995. 1 later device descends from it.

Decided
Oct 4, 2018
Review
37 days
Class
Class II
Product code
MOF
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K953533 (1995). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 5 generations backK953533 Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp. · 1995
  2. 4 generations backK961445 Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp. · 1996
  3. 3 generations backK063695 Runthrough NSTerumo Medical Corp. · 2007 · Recalled
  4. 2 generations backK080863 Traxcess 0.014 Hydrophilic GuidewireMicroVention, Inc. · 2008
  5. 1 generation backK133725 Traxcess 14 GuidewireMicroVention, Inc. · 2014
  6. This deviceK182337 HYBRID GuidewireBalt USA, LLC · 2018
  7. Descendant · cites it directly · 0 of its ownK252011 CHIKAI Nexus petitAsahi Intecc Co., Ltd. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252011CHIKAI Nexus petitAsahi Intecc Co., Ltd. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K953533Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp.1995—
−4K961445Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp.1996—
−3K063695Runthrough NSTerumo Medical Corp.20071
−2K080863Traxcess 0.014 Hydrophilic GuidewireMicroVention, Inc.2008—
−1K133725Traxcess 14 GuidewireMicroVention, Inc.2014—
0 (this device)K182337HYBRID GuidewireBalt USA, LLC2018—
+1K252011CHIKAI Nexus petitAsahi Intecc Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K182337, 1995–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MOF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MOF device

  1. #1 K253168 0.014” Willow Guidewirescore 17.9 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133725Traxcess 14 Guidewire
Summary page 4
…ion of Neurological and Physical Medicine Devices (Office of Device Evaluation, CDRH) PREDICATE DEVICE [807.92(a)(3)] Traxcess 14 Guidewire (K133725) REFERENCE DEVICES Traxcess 0.007” Mini Guidewire (K161803) Transend 300 ES Guidewire and Transend 300 Floppy Guidewire (K02235…
MicroVention, Inc.2014—
†K161803Traxcess .007 Mini GuidewireMicroVention, Inc.20161
†K022357Transend 300 ES Guidewire, Model 46-814 & Transend 300 Floppy Guidewire, Model 46-815Boston Scientific, Target2002—

Also cleared against K133725: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252011CHIKAI Nexus petitAsahi Intecc Co., Ltd.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 4.2 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K252011 (Asahi Intecc Co., Ltd., 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K133725.

How does its category compare?

All MOF devices

MOF Guide, Wire, Catheter, Neurovasculature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · MOF

11so far in 2026, the most since 2007

2011: 22014: 22015: 32016: 42017: 12018: 22019: 42020: 42022: 12023: 42024: 22025: 52026 (partial year): 11
2007high 11 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MOF

172in 2025

2015: 133 days median2016: 61 days median2019: 58 days median2020: 36 days median2023: 199 days median2025: 172 days median2026 (partial year): 192 days median
2007high 199 (2023) · low 36 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MOF

No recall names MOF since 2007.

Adverse event reports per year · MOF

135in 2025

2008: 12012: 22013: 22015: 52016: 32017: 152018: 112019: 122020: 182021: 392022: 922023: 912024: 952025: 135
2007high 135 (2025) · low 0 (2007)2025

MAUDE reports naming product code MOF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—00
20100—00
20112—00
20120—02
20130—02
20142—00
2015313305
201646103
20171—015
20182—011
2019458012
2020436018
20210—039
20221—092
20234199091
20242—095
202551720135
2026111920—

What is it indicated for?

The HYBRID Guidewire is intended for general intravascular use, including the neuro and peripheral vasculature. The guidewire can be steered to facilitate the selective placement of diagnostic or therapeutic catheters. This device is not intended for use in the coronary arteries.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K182337: HYBRID Guidewire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K182337

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026